| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/15/2015 | WO2015004163A1 Anti-tau monoclonal antibodies |
| 01/15/2015 | WO2015004038A1 ANTIBODIES TO β2-GLYCOPROTEIN I AND THERAPEUTIC USES THEREOF |
| 01/15/2015 | WO2015003675A1 Method for quantitative characterization of substances for their binding to amyloid-ss (ass) conformers |
| 01/15/2015 | US20150018748 Chitosan-derived compositions |
| 01/15/2015 | US20150018526 Cytotoxins comprising modified bouganin toxin for the treatment of cancer |
| 01/15/2015 | US20150017684 Streptococcus pyogenes antigens and corresponding dna fragments |
| 01/15/2015 | US20150017251 Microparticles for use in immunogenic compositions |
| 01/15/2015 | US20150017207 Methods and Compositions for Activation of Innate Immune Responses Through RIG-I Like Receptor Signaling |
| 01/15/2015 | US20150017206 Arranging interaction and back pressure chambers for microfluidization |
| 01/15/2015 | US20150017205 High titer recombinant influenza viruses with enhanced replication in mdck or vero cells or eggs |
| 01/15/2015 | US20150017204 Live bacterial vaccines resistant to carbon dioxide (co2), acidic ph and/or osmolarity for viral infection prophylaxis or treatment |
| 01/15/2015 | US20150017202 Synthetic toll-like receptor-4 (tlr-4) agonist peptides |
| 01/15/2015 | US20150017201 Novel nicotine dna vaccines |
| 01/15/2015 | US20150017199 Cholera toxin chimera and its use as a staph vaccine |
| 01/15/2015 | US20150017196 Computationally optimized broadly reactive antigens for h5n1 and h1n1 influenza viruses |
| 01/15/2015 | US20150017193 Rab6kifl/kif20a epitope peptide and vaccines containing the same |
| 01/15/2015 | US20150017191 Adjuvant formulations comprising tlr4 agonists and methods of using the same |
| 01/15/2015 | US20150017185 Method to improve the immune function of t cells |
| 01/15/2015 | US20150017182 Methods for treating nasal polyposis by administering an il-4r antagonist |
| 01/15/2015 | US20150017181 Prevention of infection |
| 01/15/2015 | US20150017179 Method of Treatment and Bioassay Involving Macrophage Migration Inhibitory Factor (MIF) as Cardiac-Derived Myocardial Depressant Factor |
| 01/15/2015 | US20150017178 Anti-CD26 Antibodies and Uses Thereof |
| 01/15/2015 | US20150017177 Injectable, Non-Aqueous Suspension with High Concentration of Therapeutic Agent |
| 01/15/2015 | US20150017176 Methods for treating eosinophilic esophagitis by administering an il-4r inhibitor |
| 01/15/2015 | US20150017175 Methods of administering anti-tnfalpha antibodies |
| 01/15/2015 | US20150017174 Composition |
| 01/15/2015 | US20150017172 Pharmaceutical composition for treatment and/or prevention of cancer |
| 01/15/2015 | US20150017171 Methods and Agents for the Diagnosis and Treatment of Hepatocellular Carcinoma |
| 01/15/2015 | US20150017170 Biomarker for selecting a subject for application of an anti-c-met antibody |
| 01/15/2015 | US20150017168 Dual variable domain immunoglobulins and uses thereof |
| 01/15/2015 | US20150017166 Regulation of glucose metabolism using anti-cgrp antibodies |
| 01/15/2015 | US20150017165 MONOCLONAL ANTIBODIES THAT INHIBIT THE Wnt SIGNALING PATHWAY AND METHODS OF PRODUCTION AND USE THEREOF |
| 01/15/2015 | US20150017164 COMBINATION OF BLyS AND/OR APRIL INHIBITION AND IMMUNOSUPPRESSANTS FOR TREATMENT OF AUTOIMMUNE DISEASE |
| 01/15/2015 | US20150017163 Methods for Treating or Preventing Ophthalmological Conditions |
| 01/15/2015 | US20150017160 Combinations and uses thereof |
| 01/15/2015 | US20150017158 Tetrahydrofolates in combination with egfr-inhibitors |
| 01/15/2015 | US20150017157 Methods for treating acne |
| 01/15/2015 | US20150017156 Esx-mediated transcription modulators and related methods |
| 01/15/2015 | US20150017154 Anti-nerve growth factor antibodies and methods of preparing and using the same |
| 01/15/2015 | US20150017121 Combination medicament comprising il-12 and an agent for blockade of t-cell inhibitory molecules for tumour therapy |
| 01/15/2015 | US20150017120 Synergistic tumor treatment with extended-pk il-2 and adoptive cell therapy |
| 01/15/2015 | US20150017105 Anhydrous hydrogel composition and delivery system |
| 01/15/2015 | US20150017091 Detection and treatment of metastatic disease |
| 01/14/2015 | EP2824183A1 Antibody substituting for function of blood coagulation factor VIII |
| 01/14/2015 | EP2824182A1 Method for stimulating t cell and use thereof |
| 01/14/2015 | EP2824114A1 Pharmaceutical composition for treatment and/or prevention of cancer |
| 01/14/2015 | EP2824111A2 Anti-C5A Antibodies and Methods for Using the Antibodies |
| 01/14/2015 | EP2823825A1 Pharmaceutical composition for treating cancer |
| 01/14/2015 | EP2823824A1 Pharmaceutical composition containing peptide |
| 01/14/2015 | EP2823821A1 Antibody specifically binding to digoxigenin |
| 01/14/2015 | EP2822967A1 Compositions comprising secretory-like immunoglobulins |
| 01/14/2015 | EP2822595A1 Use of sphingosine-1 -phosphate receptors modulators for improving vaccine immunization |
| 01/14/2015 | EP2822594A1 Methods of treatment with angiopoietin-2 antibodies |
| 01/14/2015 | EP2822593A1 Compositions and methods for treating cancer |
| 01/14/2015 | EP2822592A1 Tgf- 1 specific antibodies and methods and uses thereof |
| 01/14/2015 | EP2822591A1 Pharmaceutical formulations of tnf-alpha antibodies |
| 01/14/2015 | EP2822590A1 Il-17 antibody formulation |
| 01/14/2015 | EP2822589A1 Adjuvanted formulations of rabies virus immunogens |
| 01/14/2015 | EP2822588A1 Combination therapy of antibodies against human csf-1r and uses thereof |
| 01/14/2015 | EP2822587A1 Abeta antibody formulation |
| 01/14/2015 | EP2822586A1 Adjuvanted formulations of streptococcus pneumoniae antigens |
| 01/14/2015 | EP2822585A1 Improved vaccination against influenza |
| 01/14/2015 | EP2822584A1 Combination vaccines with tlr4 agonists |
| 01/14/2015 | EP2822583A2 Neisseria meningitidis compositions and methods thereof |
| 01/14/2015 | EP2822582A1 Multivalent vaccine protection from staphylococcus aureus infection |
| 01/14/2015 | EP2822581A2 Adjuvanted formulations of dtp booster vaccines |
| 01/14/2015 | EP2822580A2 Methods of inhibiting gonad maturation |
| 01/14/2015 | EP2822575A1 Engineered antibody-interferon mutant fusion molecules |
| 01/14/2015 | EP2822574A1 Methods for modulation of phosphorus and fgf23 |
| 01/14/2015 | EP2822570A1 Erythropoiesis |
| 01/14/2015 | CN104284978A 植物中类轮状病毒颗粒的产生 Generating plants class rotavirus particles |
| 01/14/2015 | CN104284678A 人抗cd27抗体、方法和用途 Human anti-cd27 antibodies, methods and uses |
| 01/14/2015 | CN104284677A 用于肿瘤诊断和治疗的组合物和方法 Compositions and methods for tumor diagnosis and treatment |
| 01/14/2015 | CN104284676A 用于纯化单克隆抗体的结晶方法 Crystallization process for purification of monoclonal antibodies |
| 01/14/2015 | CN104284675A 具有抗肿瘤活性的新颖结合分子 Novel anti-tumor activity of binding molecules |
| 01/14/2015 | CN104284674A 前列腺相关抗原及基于疫苗的免疫治疗疗法 Prostate-associated antigen and vaccine-based immunotherapy therapy |
| 01/14/2015 | CN104284670A 用于治疗丙型肝炎病毒的药剂 Medicament for the treatment of hepatitis C virus |
| 01/14/2015 | CN104278046A 乙型肝炎病毒和沙眼衣原体嵌合核酸疫苗及其用途 Hepatitis B virus and Chlamydia trachomatis chimeric DNA vaccine and its use |
| 01/14/2015 | CN104278014A 流感血凝素和神经氨酸酶变体 Influenza hemagglutinin and neuraminidase variants |
| 01/14/2015 | CN104278013A 一种抗人组织转谷氨酰胺酶2的单克隆抗体及其应用 An anti-human tissue transglutaminase 2 monoclonal antibody and its application |
| 01/14/2015 | CN104277116A 一种融合蛋白及其疫苗组合物的制备与应用 Preparation and Application of a protein vaccine composition and fusion |
| 01/14/2015 | CN104277115A 一种融合蛋白及其疫苗组合物的制备与应用 Preparation and Application of a protein vaccine composition and fusion |
| 01/14/2015 | CN104277114A 一种新的融合蛋白及用其制备的嗜肺军团菌疫苗 A new fusion protein and Legionella pneumophila bacteria vaccine used in their preparation |
| 01/14/2015 | CN104274839A 一种基因疫苗载体、其制备方法及应用 A genetic vaccine vector, its preparation method and application |
| 01/14/2015 | CN104274830A 一种基于抗原共价结合壳聚糖纳米粒的鼻腔免疫载体 Based on chitosan nanoparticles covalently bound antigen nasal immune carrier |
| 01/14/2015 | CN104274829A 一种疫苗组合物及其制备方法和应用 A vaccine composition and preparation method and application |
| 01/14/2015 | CN103861107B 一种药物组合物及其用途 A pharmaceutical composition and use thereof |
| 01/14/2015 | CN103550772B 伪狂犬病毒疫苗的生产方法 Pseudorabies virus vaccine production methods |
| 01/14/2015 | CN103360477B 经修饰的4型丙型肝炎病毒包膜e2蛋白及其应用 4 modified hepatitis C virus envelope protein and its application e2 |
| 01/14/2015 | CN103360475B 经修饰的5型丙型肝炎病毒包膜e2蛋白及其应用 5 modified hepatitis C virus envelope protein and its application e2 |
| 01/14/2015 | CN103360474B 经修饰的3a型丙型肝炎病毒包膜E2蛋白及其应用 3a modified hepatitis C virus E2 envelope protein and its application |
| 01/14/2015 | CN103360473B 经修饰的6型丙型肝炎病毒包膜e2蛋白及其应用 6 modified hepatitis C virus envelope protein and its application e2 |
| 01/14/2015 | CN103343102B 猪链球菌2型htpsC基因敲除突变株及其应用 Streptococcus suis type 2 htpsC knockout mutant and its application |
| 01/14/2015 | CN103338785B Bvdv疫苗 Bvdv vaccine |
| 01/14/2015 | CN103319593B 一种抗StxII单克隆抗体 An anti StxII monoclonal antibody |
| 01/14/2015 | CN103266091B A型口蹄疫重组疫苗株及其制备方法和应用 A recombinant vaccine strain of foot and mouth disease and its preparation method and application |
| 01/14/2015 | CN103242448B 一种全人源化抗pd-1单克隆抗体及其制备方法和应用 One kind of fully human anti-pd-1 monoclonal antibody and its preparation method and application |
| 01/14/2015 | CN103160474B 肠道病毒71型病毒株、疫苗、动物模型建立方法 Enterovirus 71 virus strains, vaccines, animal model method |
| 01/14/2015 | CN103118704B 经修饰的病毒株及用于改善流感病毒的疫苗种子的产生的方法 The method and the modified strain of influenza virus vaccines for improving seed produced |
| 01/14/2015 | CN103102392B 一种维甲酸诱导蛋白16n端多肽及其抗体的制备方法和应用 One kind of retinoic acid-inducible protein 16n terminal peptide antibody and its preparation method and application of |